Moderna Inc (MRNA) — Capital Reinvestment Ratio
Latest as of December 2025:
0.04x
Moderna Inc (MRNA) has a Capital Reinvestment Ratio of 0.04x as of December 2025, meaning it reinvests 0% of its operating cash flow ($951.00 Million) in capital expenditures ($39.00 Million). See free cash flow generation of Moderna Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.04x
Capex / Operating Cash Flow
Operating Cash Flow
$951.00 Million
USD
Capital Expenditures
$39.00 Million
USD
Data as of
Dec 2025
Most recent filing
Moderna Inc Capital Reinvestment Ratio (2016–2022)
This chart tracks Moderna Inc's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for Moderna Inc (2016–2022)
Year-by-year Capital Reinvestment Ratio for Moderna Inc from 2016 to 2022. For live market cap and broader valuation context, see Moderna Inc market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.08x | $4.98 Billion | $400.00 Million | ▲ +285.1% |
| 2021 | 0.02x | $13.62 Billion | $284.00 Million | ▼ -37.3% |
| 2020 | 0.03x | $2.03 Billion | $67.45 Million | ▼ -93.3% |
| 2016 | 0.50x | $66.73 Million | $33.14 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow